- Home
- ADMA vs MARA Comparison
ADMA vs MARA Comparison
Compare ADMA & MARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- MARA
- Stock Information
- Founded
- ADMA 2004
- MARA 2010
- Country
- ADMA United States
- MARA United States
- Employees
- ADMA N/A
- MARA N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- MARA EDP Services
- Sector
- ADMA Health Care
- MARA Technology
- Exchange
- ADMA Nasdaq
- MARA Nasdaq
- Market Cap
- ADMA 4.1B
- MARA 4.6B
- IPO Year
- ADMA N/A
- MARA N/A
- Fundamental
- Price
- ADMA $17.91
- MARA $12.16
- Analyst Decision
- ADMA Strong Buy
- MARA Buy
- Analyst Count
- ADMA 4
- MARA 12
- Target Price
- ADMA $22.50
- MARA $22.80
- AVG Volume (30 Days)
- ADMA 2.7M
- MARA 43.9M
- Earning Date
- ADMA 03-03-2025
- MARA 05-08-2025
- Dividend Yield
- ADMA N/A
- MARA N/A
- EPS Growth
- ADMA N/A
- MARA 62.77
- EPS
- ADMA 0.81
- MARA 1.72
- Revenue
- ADMA $426,454,000.00
- MARA $656,378,000.00
- Revenue This Year
- ADMA $16.18
- MARA $58.45
- Revenue Next Year
- ADMA $23.92
- MARA $11.92
- P/E Ratio
- ADMA $22.12
- MARA $7.05
- Revenue Growth
- ADMA 65.15
- MARA 69.38
- 52 Week Low
- ADMA $5.88
- MARA $12.05
- 52 Week High
- ADMA $23.64
- MARA $30.28
- Technical
- Relative Strength Index (RSI)
- ADMA 58.84
- MARA 33.54
- Support Level
- ADMA $15.88
- MARA $12.71
- Resistance Level
- ADMA $18.25
- MARA $13.84
- Average True Range (ATR)
- ADMA 1.12
- MARA 1.43
- MACD
- ADMA 0.25
- MARA -0.02
- Stochastic Oscillator
- ADMA 86.13
- MARA 2.63
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About MARA Marathon Digital Holdings Inc.
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value.